Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
10.1007/s10147-021-01869-0
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
SPRINGER JAPAN KK
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/218517 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-218517 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2185172023-10-31T08:21:27Z Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations Chang, Gee-Chen Lam, David Chi-Leung Tsai, Chun-Ming Chen, Yuh-Min Shih, Jin-Yuan Aggarwal, Shyam Wang, Shuhang Kim, Sang-We Kim, Young-Chul Wahid, Ibrahim Li, Rubi Lim, Darren Wan-Teck Sriuranpong, Virote Chan, Raymond Tsz-Tong Lorence, Robert M Carriere, Philippe Raabe, Christina Cseh, Agnieszka Park, Keunchil DUKE-NUS MEDICAL SCHOOL Science & Technology Life Sciences & Biomedicine Oncology Afatinib HER2 mutations Lung cancer Named patient use NSCLC Uncommon EGFR mutations 10.1007/s10147-021-01869-0 INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 26 5 841-850 2022-04-07T03:54:00Z 2022-04-07T03:54:00Z 2021-03-30 2022-04-07T02:15:30Z Article Chang, Gee-Chen, Lam, David Chi-Leung, Tsai, Chun-Ming, Chen, Yuh-Min, Shih, Jin-Yuan, Aggarwal, Shyam, Wang, Shuhang, Kim, Sang-We, Kim, Young-Chul, Wahid, Ibrahim, Li, Rubi, Lim, Darren Wan-Teck, Sriuranpong, Virote, Chan, Raymond Tsz-Tong, Lorence, Robert M, Carriere, Philippe, Raabe, Christina, Cseh, Agnieszka, Park, Keunchil (2021-03-30). Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 26 (5) : 841-850. ScholarBank@NUS Repository. https://doi.org/10.1007/s10147-021-01869-0 13419625 14377772 https://scholarbank.nus.edu.sg/handle/10635/218517 en SPRINGER JAPAN KK Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Oncology Afatinib HER2 mutations Lung cancer Named patient use NSCLC Uncommon EGFR mutations |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Oncology Afatinib HER2 mutations Lung cancer Named patient use NSCLC Uncommon EGFR mutations Chang, Gee-Chen Lam, David Chi-Leung Tsai, Chun-Ming Chen, Yuh-Min Shih, Jin-Yuan Aggarwal, Shyam Wang, Shuhang Kim, Sang-We Kim, Young-Chul Wahid, Ibrahim Li, Rubi Lim, Darren Wan-Teck Sriuranpong, Virote Chan, Raymond Tsz-Tong Lorence, Robert M Carriere, Philippe Raabe, Christina Cseh, Agnieszka Park, Keunchil Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| description |
10.1007/s10147-021-01869-0 |
| author2 |
DUKE-NUS MEDICAL SCHOOL |
| author_facet |
DUKE-NUS MEDICAL SCHOOL Chang, Gee-Chen Lam, David Chi-Leung Tsai, Chun-Ming Chen, Yuh-Min Shih, Jin-Yuan Aggarwal, Shyam Wang, Shuhang Kim, Sang-We Kim, Young-Chul Wahid, Ibrahim Li, Rubi Lim, Darren Wan-Teck Sriuranpong, Virote Chan, Raymond Tsz-Tong Lorence, Robert M Carriere, Philippe Raabe, Christina Cseh, Agnieszka Park, Keunchil |
| format |
Article |
| author |
Chang, Gee-Chen Lam, David Chi-Leung Tsai, Chun-Ming Chen, Yuh-Min Shih, Jin-Yuan Aggarwal, Shyam Wang, Shuhang Kim, Sang-We Kim, Young-Chul Wahid, Ibrahim Li, Rubi Lim, Darren Wan-Teck Sriuranpong, Virote Chan, Raymond Tsz-Tong Lorence, Robert M Carriere, Philippe Raabe, Christina Cseh, Agnieszka Park, Keunchil |
| author_sort |
Chang, Gee-Chen |
| title |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| title_short |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| title_full |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| title_fullStr |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| title_full_unstemmed |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
| title_sort |
experience from asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon egfr mutations |
| publisher |
SPRINGER JAPAN KK |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/218517 |
| _version_ |
1781793039687090176 |